Jesduvroq Tablet, Film Coated
Product Images NDC 0173-0897

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Jesduvroq (NDC 0173-0897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

N [(1,3 Dicyclohexylhexahydro-2,4,6-trioxopyrimidin-5-yl) Carbonyl]glycine Chemical Structure (Jesduvroq Spl Graphic 01)

Chemical structure of daprodustat, the active ingredient in Jesduvroq tablets. The diagram shows the molecular structure with rings, amide groups, and a carboxyl functional group, consistent with daprodustat's chemical composition.*

FDA Label Image

Jesduvroq 1 mg Tablet 30 Count Label (Jesduvroq Spl Graphic 02)

Jesduvroq (daprodustat) tablets 1 mg tablet film-coated oral dosage form. The label shows a package containing 30 tablets. Manufactured by GlaxoSmithKline LLC, Durham, NC, with product origin noted as Singapore. The label includes storage instructions and a warning not to use if the printed safety seal under the cap is broken or missing.*

FDA Label Image

Jesduvroq 2 mg Tablet 30 Count Label (Jesduvroq Spl Graphic 03)

Jesduvroq (daprodustat) 2 mg film-coated tablets label showing oral dosage form. The label includes storage instructions, a warning about the safety seal under the cap, and manufacturer details GlaxoSmithKline LLC, Durham, NC. The package contains 30 tablets. It advises swallowing tablets whole without cutting or crushing.*

FDA Label Image

Jesduvroq 4 mg Tablet 30 Count Label (Jesduvroq Spl Graphic 04)

Jesduvroq (daprodustat) 4 mg film-coated tablets packaging label, showing prescription drug status, strength, and quantity of 30 tablets. The label includes storage instructions, a warning about the safety seal, manufacturing details by GlaxoSmithKline LLC, and batch information. The label is designed for oral administration.*

FDA Label Image

Jesduvroq 6 mg Tablet 30 Count Label (Jesduvroq Spl Graphic 05)

Jesduvroq 6 mg tablets film coated, oral dosage form, containing daprodustat. The label shows 30 tablets per container. It includes instructions to swallow tablets whole without cutting, crushing, or chewing. The product is manufactured by GlaxoSmithKline LLC, Durham, NC, and produced in Singapore. The label also states storage conditions and safety warnings about the printed safety seal under the cap.*

FDA Label Image

Jesduvroq 8 mg Tablet 30 Count Label (Jesduvroq Spl Graphic 06)

Jesduvroq (daprodustat) tablets 8 mg film-coated oral tablets, supplied in a bottle containing 30 tablets. The label includes storage instructions, usage warnings, and manufacturer information for GlaxoSmithKline LLC. The tablet is brown and round with an imprint visible in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.